Lonza  
Careers @ Lonza | Contact us | Sitemap |
Shop
 
Home > Company > Media Center > News Archive > 2007 > Lonza increases capacity for amine production
 
Lonza increases capacity for amine production
print    
Media Releases Financial Reports Presen-tations
01/29/2007      
 


Basel, 29 January 2007 – Lonza, the global life sciences company, announces the building of a performance chemicals plant in Nanjing, China. The set-up of a performance chemicals production base in China using state of the art technology has been initiated to augment long-term strategic supply relationships serving captive demand. The facility will come on stream in the second half of 2008. In parallel, the introduction of the innovative direct amination technology in Mapleton, IL (USA) in order to secure market leadership in North America is well under way.

The increase of the production capacity is a strategic move to strengthen the position of Lonza’s Fine chemicals and performance chemicals division in the growing market.

Products from the plant will be used in antimicrobial applications.



About Lonza
Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers’ needs from research to final product manufacture. Lonza is the global leader in the production and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also a leading provider of value chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.

Lonza is headquartered in Basel, Switzerland and is listed on the SWX Swiss Exchange. In 2006 Lonza had sales of CHF 2.91 billion. Further information can be found at www.lonza.com.

For further information:

Investor Relations /Media inquiries:
Lonza Ltd
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com

Media inquiries German:
Lonza Ltd
Dominik Werner
Tel +46 61 316 8798
Fax +41 61 316 9798
Mobile +41 79 470 6308
dominik.werner@lonza.com


Disclaimer